Exosome Diagnostics Investors

35 investors on Angel Roster list Exosome Diagnostics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the Netherlands, the United States and Germany.

Investors are matched on the company name in their portfolio, so companies that share the name Exosome Diagnostics can appear together.

Investors listed
35
With verified email
29%
Most common stage
Seed
Top location
Netherlands

Updated October 13, 2026 · How we compile this data

Top 35 Exosome Diagnostics investors

The most complete profiles first. Showing 35 of 35.

  • Anna BoschVerified

    Venture Capital, Investor · Germany

    Series AHealth CareE-commerceEnterprise SoftwareFleet Management

    Portfolio: Arktis Radiation Detectors, Demecan, Ava, neptune.ai and 72 more

    Verified email available

  • Antoine BoulangerVerified

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Verified email available

  • Jochen GutbrodVerified

    Venture Capital, Investor · Italy

    Series AHealth CareE-commerceFleet ManagementTransportation

    Portfolio: Arktis Radiation Detectors, Demecan, Ava, neptune.ai and 72 more

    Verified email available

  • Anastasia KarpovaVerified

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Verified email available

  • Jennifer PhanVerified

    Venture Capital · Germany

    Health CareE-commerceFleet ManagementTransportation

    Portfolio: Arktis Radiation Detectors, Demecan, Ava, neptune.ai and 72 more

    Verified email available

  • John MontanaVerified

    Venture Capital, Private Equity Firm, Investment Partner · United Kingdom

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Verified email available

  • Ken AbramowitzVerified

    Venture Capital · United States

    Health CareHospitalsGeneticsBiotechnology

    Portfolio: Nitec Pharma AG, Valtech Cardio, Vivaldi Biosciences, EKOS Corporation and 13 more

    Verified email available

  • Luca MartinelliVerified

    Venture Capital · Germany

    Health CareE-commerceFleet ManagementTransportation

    Portfolio: Arktis Radiation Detectors, Demecan, Ava, neptune.ai and 72 more

    Verified email available

  • Christian Guba

    Venture Capital, Investor · Germany

    SeedHealth CareE-commerceFleet ManagementTransportation

    Portfolio: Arktis Radiation Detectors, Demecan, Ava, neptune.ai and 72 more

    Contact details available

  • Geert

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Holger Reithinger

    Venture Capital, Investor · Germany

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more

    Contact details available

  • Julian Riebartsch

    Venture Capital, Investor · Switzerland

    Series AHealth CareE-commerceDeepTechFleet Management

    Portfolio: Arktis Radiation Detectors, Demecan, Ava, neptune.ai and 72 more

    Contact details available

  • Juliette Audet

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Martien van Osch

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more

    Contact details available

  • Michael Wieser

    Venture Capital, Angel/Individual, Investor · Germany

    SeedPre-SeedAdvertisingHealth CareE-commerceFleet Management

    Portfolio: Arktis Radiation Detectors, Demecan, Ava, neptune.ai and 72 more

    Contact details available

  • Robert Gallenberger

    Venture Capital, Investor · Germany

    Series AHealth CareE-commerceEnterprise SoftwareFleet Management

    Portfolio: Arktis Radiation Detectors, Demecan, Ava, neptune.ai and 74 more

    Contact details available

  • Rogier Rooswinkel

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Wouter Joustra

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Alessandro BoninsegnaVerified

    Private Equity Firm · United Kingdom

    Health CareTelecommunicationsGeneticsE-commerce

    Portfolio: Strategic Venue Partners, LendInvest, SmartSky Networks, Exosome Diagnostics and 4 more

    Contact details available

  • Emil HenryVerified

    Private Equity Firm · United States

    Health CareTelecommunicationsGeneticsE-commerce

    Portfolio: Strategic Venue Partners, LendInvest, SmartSky Networks, Exosome Diagnostics and 4 more

    Verified email available

  • Marc BlairVerified

    Private Equity Firm · United States

    Health CareTelecommunicationsGeneticsE-commerce

    Portfolio: Strategic Venue Partners, LendInvest, SmartSky Networks, Exosome Diagnostics and 4 more

    Verified email available

  • Alexander Cuomo

    Venture Capital · United States

    Health CareHospitalsGeneticsBiotechnology

    Portfolio: Nitec Pharma AG, Valtech Cardio, Vivaldi Biosciences, EKOS Corporation and 13 more

    Contact details available

  • Andreas Goeldi

    Venture Capital · Switzerland

    Health CareE-commerceFleet ManagementTransportation

    Portfolio: Arktis Radiation Detectors, Demecan, Ava, neptune.ai and 72 more

    Contact details available

  • Asiya Giniatullina

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Bonnie van Wilgenburg

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Carlo Incerti

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Christian Schütz

    Venture Capital · Switzerland

    Health CareE-commerceFleet ManagementTransportation

    Portfolio: Arktis Radiation Detectors, Demecan, Ava, neptune.ai and 72 more

    Contact details available

  • John Costantino

    Venture Capital · United States

    Health CareHospitalsGeneticsBiotechnology

    Portfolio: Nitec Pharma AG, Valtech Cardio, Vivaldi Biosciences, EKOS Corporation and 13 more

    Contact details available

  • Maximilian Kempken

    Venture Capital · Germany

    Health CareE-commerceFleet ManagementTransportation

    Portfolio: Arktis Radiation Detectors, Demecan, Ava, neptune.ai and 72 more

    Contact details available

  • Sander van Deventer

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Stefano L. Saeger

    Venture Capital · Switzerland

    Health CareE-commerceFleet ManagementTransportation

    Portfolio: Arktis Radiation Detectors, Demecan, Ava, neptune.ai and 72 more

    Contact details available

  • Vincent van Houten

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Adam Emmert

    Private Equity Firm · United States

    Health CareTelecommunicationsGeneticsE-commerce

    Portfolio: Strategic Venue Partners, LendInvest, SmartSky Networks, Exosome Diagnostics and 4 more

    Contact details available

  • Chad Hellmann

    Private Equity Firm · United States

    Health CareHospitalsGeneticsAccounting

    Portfolio: Epic Sciences, TRACON Pharmaceuticals, T2 Biosystems, XTuit Pharmaceuticals and 4 more

    Contact details available

  • Steven Soignet, MD

    Venture Capital, Angel/Individual · United States

    Health CareHospitalsGeneticsLife Science

    Portfolio: Exosome Diagnostics

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Exosome Diagnostics investors are on Angel Roster?

Angel Roster lists 35 Exosome Diagnostics investors. 10 of them (29%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (30), Private Equity Firms (11) and Investment Partner Investors (6). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Exosome Diagnostics investors invest in?

Among those that list a stage, the most common are Seed (9), Series A (4) and Pre-Seed (1).

Where are Exosome Diagnostics investors based?

Most are based in the Netherlands (12), the United States (8) and Germany (8).

Which companies have Exosome Diagnostics investors backed?

The most-backed portfolio companies among them are Cardoz (14), Allecra Therapeutics (14), NorthSea Therapeutics (14), Pathway Medical Technologies (14) and Curetis (14).

How do I contact Exosome Diagnostics investors?

Create a free Angel Roster account to search and filter all 35, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.